Search results

Selected filters:

Law & Policy
News

Article type

Topic

Sector

Regions

Year

293 results found for your search

Sort options
13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

11 February 2019

Huawei owns the future and that’s why it’s here to stay

Deep pockets, a strong commitment to R&D and a world class 5G patent portfolio mean that whatever its current difficulties the Chinese telecoms business is set to be a major player for the long term

09 February 2019

The big life sciences patent developments in January

Record-breaking Celgene purchase, two decisions on the on-sale bar, Europe moves towards SPC manufacturing waiver, China proposes five-year patent term extension and much more

05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences

01 February 2019

We have not been informed of any Chinese antitrust investigation of us, Ericsson tells <em>IAM</em>

Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway

31 January 2019

Pressure piles on US pharma and biotech IP owners

America's life sciences innovators face accusations of using patents to build monopolies and overcharge for vital medicines. If they do not tell their side of the story and fast, they risk losing vital protections on which they rely   

23 January 2019

Kokes hails "fantastic first year" as NantWorks CIPO

In exclusive interview with IAM, after confirming as a speaker for IPBC Global 2019, the former BlackBerry IP chief talks in-depth about life sciences and high tech convergence - and the many patent opportunities that creates 

23 January 2019

Welcome to the future of patents

New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond

21 January 2019

It's time to prepare for the IP monetisation revolution

The rise of disruptive new technology means that everything you thought you knew about making money from IP is set to change

18 January 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

16 January 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so

11 January 2019

The global patent market in 10 charts

The key takeaways from WIPO’s 2018 IP indicators report   

21 December 2018

Everything you need to know about China’s new preliminary injunction rules

China will ring in the New Year with brand new PI guidance that takes effect January 1. The rules were published just days before a Fuzhou court’s high-profile injunctions against Apple

21 December 2018

Life sciences round-up - UK Supreme Court rules in landmark case, patent linkage shelved in China, big CAFC decision and much more

A summary of the major IP news from the biotechnology, pharmaceutical and medical technology sectors in November and the first-half of December

12 December 2018

Supreme Court of India set to rule in crucial plant innovation dispute

The decision in Monsanto’s appeal against the revocation of a key patent right could have profound implications on the ability to protect agro-biotech inventions in India